This site is intended for healthcare professionals outside the US


Print |

Acromegaly is a hormonal disorder caused by excessive production of human growth hormone (GH).1

  • Approximately 3–4 new cases per 1 million persons per year2
  • Approximately 40–70 cases per million2
  • Most often diagnosed in middle-aged adults, with equal occurrence in men and women3
  • Often diagnosed 4–10 years after its onset2
  • Approximately 2x greater risk of mortality compared with the general population4
To review how uncontrolled acromegaly affects the body, click here.

1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services. Acromegaly. Bethesda, MD: National Institutes of Health; 2008. NIH publication 08-3924. 2. Chanson P, Salenave S. Acromegaly. Orphanet J Rare Dis. 2008;3:1-17. 3. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary. 1999;2(1):29-41. 4. Holdaway IM, Rajasoorya C, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab. 2004;89(2):667-674.

Please see the Summary of Product Characteristics.